T cells can't see a whole germ. They read short pieces of protein held up on a molecule called MHC (major histocompatibility complex). In humans the same molecules are called HLA, for human leukocyte antigen. They're how the body shows the immune system what's inside a cell.
Two kinds of display
| MHC class I | MHC class II | |
|---|---|---|
| Found on | Almost every cell with a nucleus | Dendritic cells, macrophages, B cells, and some others when inflamed |
| Shows | What the cell is making inside itself | What the cell has swallowed from outside |
| Read by | Killer T cells (CD8) | Helper T cells (CD4) |
| Means | "This is what's going on in me" | "This is what I found out there" |
| Result if it's foreign | The cell gets killed | The helper T cell gives help |
This split fits the logic. If a cell is making viral protein, it's been taken over and should die, whereas a macrophage that's eaten a bacterium is doing its job and needs help, not killing.
Dendritic cells can also put things they swallowed onto class I. That's called cross-presentation. Without it, killer T cells could never be started against a virus that doesn't infect dendritic cells.
The most varied genes you have
HLA genes are on chromosome 6, and they're the most variable genes in the human genome, with tens of thousands of known versions in the population. You inherit a set from each parent and use both, so you have up to six class I types (HLA-A, B and C) and several class II types (HLA-DR, DQ and DP).
Each HLA type holds a different range of peptide shapes. So your HLA type decides what your T cells can see, and that differs from nearly anyone else's. Swapping the groove in the figure above shows the idea. In evolutionary terms, this means no single virus can hide from everybody: if it evades most people's HLA, it still gets caught by someone else's, and the species survives.
Why this shows up in medicine
Transplants. A large share of your T cells react to foreign HLA, because it looks like your own HLA carrying something foreign. This is why donors are matched and recipients take immunosuppressants. The word "histocompatibility" means tissue compatibility, and the system was discovered through transplant rejection.
Disease risk. Many autoimmune diseases are linked to particular HLA types, probably because those types are unusually good at showing a particular piece of self.
| HLA type | Linked with |
|---|---|
| HLA-B27 | Ankylosing spondylitis |
| HLA-DQ2, DQ8 | Coeliac disease. Nearly all patients have one, but so do about a third of all people, and most of them never get it. |
| HLA-DRB1*15:01 | Multiple sclerosis |
| HLA-DRB1*04 | Rheumatoid arthritis |
Drug reactions. People with HLA-B*57:01 can have a dangerous reaction to the HIV drug abacavir, so patients are tested first. The drug changes which peptides that one HLA type can hold.
HLA linkage only tells you about risk. Most people with a "risky" HLA type never get the disease, so the test is mainly useful when it's negative, for ruling something out: without DQ2 or DQ8, coeliac disease is very unlikely.
Who found this
Peter Doherty and Rolf Zinkernagel worked out in Canberra in the 1970s that a killer T cell only recognises a viral piece when it's held by the right MHC. That earned them the 1996 Nobel Prize, and it changed how immunologists thought about what T cells see.
MHC is the cell's display case: class I shows what a cell is making, and class II shows what it has swallowed. Your HLA type decides what your T cells can see, and it's why transplants need matching.